Blonder Tongue Laboratories (BDRL) Stock Statistics & Valuation Metrics

Blonder Tongue Laboratories has a market cap or net worth of $327.53K. The enterprise value is $13.27M.

Blonder Tongue Laboratories has 13,368,538 shares outstanding. The number of shares has decreased by -2.65% in one year.

Blonder Tongue Laboratories’s return on equity (ROE) is 0.72 and return on invested capital (ROIC) is -10.74%.

The current PE Ratio of Blonder Tongue Laboratories is -1.09. Blonder Tongue Laboratories’s PEG ratio is <0.01.

In the last 12 months, Blonder Tongue Laboratories had revenue of 11.16M and earned -1.25M in profits. Earnings per share was -0.09.

In the last 12 months, operating cash flow was 1.04M and capital expenditures -11.00K, giving a free cash flow of 1.03M billion.

Blonder Tongue Laboratories pays an annual dividend of ―, resulting in a dividend yield of ―

Blonder Tongue Laboratories upcoming earnings date is Nov 15, 2023, TBA Not Confirmed.

Blonder Tongue Laboratories as a current ratio of 0.60, with Debt / Equity ratio of 1005.77%

In the past 12 months, Blonder Tongue Laboratories has paid 12.00K in taxes.

Blonder Tongue Laboratories EV to EBITDA ratio is 21.17, with an EV/FCF ratio of 9.14.

Blonder Tongue Laboratories has $33.00K in cash and marketable securities with $8.14M in debt, giving a net cash position of $8.11M billion.

Gross margin is 30.16%, with operating margin of -6.11%, and net profit margin of -11.18%.

The average price target for Blonder Tongue Laboratories is ―, which is 11.43% higher than the current price. The consensus rating is ―